Related Experiment Videos
Appropriate clinical application of bone density measurements.
R D Wasnich1, J W Davis, P D Ross
1Osteoporosis Center, Kuakini Medical Center, Honolulu.
Journal of the American Medical Women'S Association (1972)
|May 1, 1990
Summary
Bone mass measurements effectively predict fracture risk, guiding preventive strategies like estrogen replacement for postmenopausal women. Estimating Remaining Lifetime Fracture Probability (RLFP) aids in personalized osteoporosis treatment decisions.
Area of Science:
- Osteoporosis Research
- Bone Health
- Geriatric Medicine
Background:
- Bone mass is a critical risk factor for fractures.
- Prospective studies consistently link bone mass (radius, calcaneus) to various fracture sites.
- Current bone mass levels indicate fracture risk but not disease severity.
Purpose of the Study:
- To evaluate bone mass as a predictor of fracture risk.
- To guide preventive measures, such as hormone replacement therapy, in menopausal women.
- To establish objective methods for determining osteoporosis treatment needs.
Main Methods:
- Analysis of prospective studies correlating bone mass measurements (radius, calcaneus) with fracture incidence.
- Development of Remaining Lifetime Fracture Probability (RLFP) estimation.
- Inclusion of bone mineral content (BMC), age, life expectancy, and anticipated bone loss rate in RLFP calculations.
Main Results:
- Bone mass measurements demonstrate a clear relationship with fracture risk at multiple skeletal sites.
- RLFP provides an objective estimate of future fracture probability.
- RLFP can identify individuals who would benefit from pharmacological interventions for osteoporosis.
Conclusions:
- Bone mass evaluation is crucial for assessing fracture risk and guiding preventive care in women.
- Objective risk assessment tools like RLFP are essential for personalized osteoporosis management.
- Tailoring treatment intensity to individual fracture risk levels is the ultimate goal in osteoporosis care.